Cure: The crippling pain of migraines could be solved using a gel
Rubbing anti-inflammatory gel on to your gums could prove to be an effective new treatment for migraine, which affects one in eight Britons.
The gel, which is based on a drug already used to treat painful joints and back pain, is being prescribed to patients in twoclinical trials to analyse its benefits for preventing and treating migraines.
Previous research has suggested it may be effective at preventing migraines when used once a day for three months. It is thought the gel interferes with pain signals as they travel along a key nerve, which has branches that run through the gums.
Around 17 per cent of migrainesufferers have more than 40 attacks a year. Symptoms are an intense, throbbing headache, often on one side of the head only, and can also include nausea and vomiting, and increased sensitivity to light, noise and smell.
In migraine with aura, sufferers experience visualsymptoms, including blind spots, flashing lights or zigzag patterns.
An attack can last anywhere between four hours and three days, and patients can feel drained for several days afterwards.
Attacks can be triggered by a variety of factors, from flashing light to certain foods.
Though it’s not understood exactly how migraines aretriggered, it is thought to be associated with changes in blood flow, due to narrowing of the blood vessels.
Once this has occurred, it is believed the trigeminal nerve, the major sensory nerve in the head and face,transmits migraine pain signals. Scientists think that interfering with the signal transmission could block the sensations of pain.
In the trials, doctors are using a gel based on ketoprofen, a non-steroidal anti-inflammatory drug (NSAID).
The drug blocks theproduction of prostaglandins— compounds that are involved in producing inflammation and pain. The rub-on gel is already used to treat sprains and osteo-arthritis. In the migraine trials, a swab loaded with the gel is pressed on to the patient’s gum and held in place above two back molars for two minutes.
Researchers are studying its effectiveness in preventing and treating migraine attacks.
In the prevention trial, which starts this month, the gel will be given once a day to 100 people with a history of four or more migraines a month.
They will be asked to record how often they have an attack, and how much medication they use.
In the treatment trial, patients will rub on the gel when an attack begins, and can repeat thetreatment 20 minutes later.
‘The research with ketoprofen, which is given via the gums, is interesting,’ says Dr Andrew Dowson, head of headache services at KingsCollege Hospital, London.
‘NSAIDs are excellent anti-inflammatories and painkillers. This is a novel delivery method that avoids taking tablets.
‘It’s much more attractive for patients suffering from nausea who risk vomiting before atablet has been absorbed.’
Taking a combination ofstatins and vitamin D may help to combat migraine attacks.
Researchers in Boston, U.S., are giving sufferers of so-calledepisodic migraine— where patients suffer from fewer than 14 headache days a month— a daily combination of the vitamin and statins, which are used to treat high cholesterol.
Nearly 100 people are involved in the nine-month clinical trial at the Beth Israel Deaconess Medical Centre.
Scientists believe the drugs could have a beneficial effect on migraine because statins have an anti-inflammatory effect, having been shown in aseparate study at Oregon University, U.S., to reduce the inflammation in brain cells caused by migraine.
Vitamin D also has an anti-inflammatory effect, and research at the Ryan Wheeler Headache Treatment Centre, in the U.S., has shown that 41 per cent of people who suffer from migraines had low levels of this vitamin.
Taking a combination of statins and vitamin D may help to combat migraine attacks. Researchers in Boston, U.S., are giving sufferers of so-called episodic migraine— where patients suffer from fewer than 14 headache days a month— a daily combination of the vitamin and statins, which are used to treat high cholesterol.
Nearly 100 people are involved in the nine-month clinical trial at the Beth Israel Deaconess Medical Centre.
Scientists believe the drugs could have a beneficial effect on migraine because statins have an anti-inflammatory effect, having been shown in a separate study at Oregon University, U.S., to reduce the inflammation in brain cells caused by migraine.
Vitamin D also has an anti-inflammatory effect, and research at the Ryan Wheeler Headache Treatment Centre, in the U.S., has shown that 41 per cent of people who
suffer from migraines had low levels of this vitamin.